AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-1.48%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$393M
AUM Growth
+$393M
(+6.9%)
Cap. Flow
+$29.3M
Cap. Flow
% of AUM
7.44%
Top 10 Holdings %
Top 10 Hldgs %
80.79%
Holding
223
New
14
Increased
86
Reduced
51
Closed
29
Top Buys
| 1 |
iShares MBS ETF
MBB
|
$10.8M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$10.1M |
| 3 |
Seres Therapeutics
MCRB
|
$1.15M |
| 4 |
Vuzix
VUZI
|
$1.05M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$997K |
Top Sells
| 1 |
Ouster
OUST
|
$1.06M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$998K |
| 3 |
Travere Therapeutics
TVTX
|
$897K |
| 4 |
ADC Therapeutics
ADCT
|
$633K |
| 5 |
Vicarious Surgical
RBOT
|
$548K |
Sector Composition
| 1 | Real Estate | 18.05% |
| 2 | Healthcare | 12.08% |
| 3 | Technology | 1.59% |
| 4 | Financials | 1.03% |
| 5 | Industrials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vuzix
VUZI
$162M
| $1.05M | 0.27% |
+100,000
| New | +$1.05M |
|
27
Puma Biotechnology
PBYI
$258M
| $1.04M | 0.26% |
148,500
+108,500
| +271% | +$761K |
|
28
ClearPoint Neuro
CLPT
$291M
| $1.02M | 0.26% |
57,500
+7,500
| +15% | +$133K |
|
29
Accuray
ARAY
$165M
| $988K | 0.25% |
250,000
+15,000
| +6% | +$59.3K |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $987K | 0.25% |
65,000
+15,000
| +30% | +$228K |
|
|
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $983K | 0.25% |
16,500
+9,000
| +120% | +$536K |
|
|
MFA
32
MFA Financial
MFA
$1.05B
| $980K | 0.25% |
53,609
+17,069
| +47% | +$312K |
|
|
TCRR
33
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $962K | 0.24% |
113,000
+72,000
| +176% | +$613K |
|
|
TRIL
34
DELISTED
Trillium Therapeutics Inc.
TRIL
| $957K | 0.24% |
54,500
+24,500
| +82% | +$430K |
|
35
Mr. Cooper
COOP
$12.1B
| $938K | 0.24% |
22,794
+3,655
| +19% | +$150K |
|
36
Aclaris Therapeutics
ACRS
$223M
| $918K | 0.23% |
51,000
+14,000
| +38% | +$252K |
|
37
Celldex Therapeutics
CLDX
$1.57B
| $918K | 0.23% |
17,000
-8,000
| -32% | -$432K |
|
|
CYBE
38
DELISTED
Cyberoptics Corp
CYBE
| $890K | 0.23% |
25,000
| – | – |
|
39
Spyre Therapeutics
SYRE
$1.02B
| $875K | 0.22% |
4,400
+700
| +19% | +$139K |
|
40
Arcutis Biotherapeutics
ARQT
$1.91B
| $848K | 0.22% |
35,500
+22,000
| +163% | +$526K |
|
41
Sarepta Therapeutics
SRPT
$1.98B
| $832K | 0.21% |
9,000
-5,000
| -36% | -$462K |
|
42
Gilead Sciences
GILD
$140B
| $803K | 0.2% |
11,500
-300
| -3% | -$20.9K |
|
43
Karyopharm Therapeutics
KPTI
$61.4M
| $792K | 0.2% |
9,067
+3,634
| +67% | +$317K |
|
44
Insmed
INSM
$30.3B
| $785K | 0.2% |
28,500
+4,500
| +19% | +$124K |
|
45
Procept Biorobotics
PRCT
$2.11B
| $763K | 0.19% |
+20,000
| New | +$763K |
|
|
SAFE
46
Safehold
SAFE
$1.16B
| $759K | 0.19% |
6,221
+5,341
| +607% | +$652K |
|
47
Axsome Therapeutics
AXSM
$6.09B
| $758K | 0.19% |
23,000
+11,000
| +92% | +$363K |
|
48
Iovance Biotherapeutics
IOVA
$800M
| $752K | 0.19% |
30,500
-3,000
| -9% | -$74K |
|
|
VIRX
49
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $741K | 0.19% |
92,402
| – | – |
|
50
Merck
MRK
$210B
| $732K | 0.19% |
9,750
-2,250
| -19% | -$169K |
|